Tyber Medical, Intech, and Resolve Surgical Technologies have merged in a unified developer, designer, and manufacturer of surgical devices.

The new group combines implant and instrumentation platforms with development and regulatory expertise to offer solutions for OEMs worldwide. It’s backed by a consortium of private investors, led by Montagu.

The group, whose merger was first announced in January, unites the strengths of three organizations into one comprehensive, innovative offering. Their portfolio will include FDA-cleared and CE-marked technologies like PEEK interbodies, plates, screws, sternal closure systems, cabling, flexible reamers, handles, and the SMADE IoT surgical asset tracking system.

The new group touts decades of clinical experience designing, developing, manufacturing and sustaining systems for the trauma, extremities, sports medicine, spine, and cardiothoracic markets. It will have about 1,500 employees at 12 sites, on three continents.

A flexible end-to-end model supports the full spectrum of customers’ needs including contract manufacturing, co-development, and private labeling as a manufacturer of record. The group also boasts a comprehensive portfolio and expertise in precision manufacturing of surgical instruments, implants, and sterilization containers, enabling accelerated development processes and simplifying supply chain management.

The company’s regulatory capabilities include filing and sustaining 510(k), EU MDR, and CE mark registrations for Class I, II, and III surgical devices.

“This is more than a merger—it’s a shared ambition to provide solutions that shape the future of musculoskeletal care,” said Salvatore Guccione, chairman and interim CEO of the newly formed company.

“By combining our strengths, we are supporting our OEMs with faster time-to-market, broader capabilities, and the confidence of a truly global partner,” added Jeff Tyber, founder of Tyber Medical and now president of the CDMO+ business.

The group has over 100 510(k)-cleared implant systems, thousands of pre-validated devices, and modular instrumentation.

“This is truly unique. We now have a comprehensive portfolio and expertise in precision manufacturing of implants, surgical instruments, and sterilization containers. Combined with our unique regulatory capabilities,” said Megan Osorio, CEO of Resolve.

The group has annual revenues of over $300 million with an exclusive focus on medical devices.

“Our customers no longer need to juggle multiple vendors to achieve agility, quality, and scale,” said Laurent Pruvost, former president and CEO of Intech and now president of the CMO business. “With one integrated team and a global footprint spanning three continents, we provide the infrastructure, flexibility, and stability needed to meet today’s dynamic supply chain demands.”